glp-1 alzheimer's 2024 GLP-1R agonists protect against disease by rewiring energy regulation GLP-1 Microdosing, Brain Health &

In a phase 3 clinical trial, Zepbound led to an average weight loss of 22.5% body weight, or about 52 pounds, surpassing all currently available weight loss medications on the market

The most frequently reported side effects of GLP-1 medications are gastrointestinal in nature

[15] The statistical likelihood of developing a UTI during a several-month course of Wegovy treatment is substantial, regardless of medication use

Others simply pick a different spot each time, making sure they maintain adequate distance from the last injection point

doi: 10.1111/bcpt.70004

Because you are on tirzepatide, and nobody told you this could happen